Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 15.47 CNY -0.9% Market Closed
Market Cap: 17.3B CNY

Wall Street
Price Targets

Price Targets Summary
Shenzhen Kangtai Biological Products Co Ltd

Wall Street analysts forecast Shenzhen Kangtai Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 19.91 CNY with a low forecast of 17.17 CNY and a high forecast of 25.62 CNY.

Lowest
Price Target
17.17 CNY
11% Upside
Average
Price Target
19.91 CNY
29% Upside
Highest
Price Target
25.62 CNY
66% Upside
Shenzhen Kangtai Biological Products Co Ltd Competitors:
Price Targets
QTTB
Homology Medicines Inc
221% Upside
VERK
Verkkokauppa.com Oyj
27% Upside
AVDL
Avadel Pharmaceuticals PLC
0% Downside
MTRX
Matrix Service Co
29% Upside
CDNA
CareDx Inc
22% Upside
UFPT
UFP Technologies Inc
13% Upside
DXPE
DXP Enterprises Inc
0% Upside

Revenue
Forecast

24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
24% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 15%.

Operating Income
Forecast

15% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss
15% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-22%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 46%.

Net Income
Forecast

21% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
21% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 42%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Kangtai Biological Products Co Ltd's stock price target?
Price Target
19.91 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 19.91 CNY with a low forecast of 17.17 CNY and a high forecast of 25.62 CNY.

What is Shenzhen Kangtai Biological Products Co Ltd's Revenue forecast?
Projected CAGR
15%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 24%. The projected CAGR for the next 3 years is 15%.

What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
46%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 15%. The projected CAGR for the next 3 years is 46%.

What is Shenzhen Kangtai Biological Products Co Ltd's Net Income forecast?
Projected CAGR
42%

For the last 10 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 21%. The projected CAGR for the next 3 years is 42%.

Back to Top